Daniel A. Pryor - Feb 25, 2022 Form 4 Insider Report for Colfax CORP (ENOV)

Role
EVP, Strategy & Business Dev.
Signature
/s/ Bradley Tandy, Attorney-in-Fact
Stock symbol
ENOV
Transactions as of
Feb 25, 2022
Transactions value $
-$1,373,267
Form type
4
Date filed
3/1/2022, 06:01 PM
Previous filing
Feb 25, 2022
Next filing
Mar 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENOV Common stock, par value $.001 Sale -$85.4K -2.02K -1.16% $42.18 172K Feb 25, 2022 Direct F1
transaction ENOV Common stock, par value $.001 Award $0 +62.8K +36.5% $0.00 235K Feb 25, 2022 Direct F2
transaction ENOV Common stock, par value $.001 Sale -$1.29M -31.3K -13.31% $41.18 204K Feb 28, 2022 Direct F1
holding ENOV Common stock, par value $.001 2.31K Feb 25, 2022 By 401K Plan
holding ENOV Common stock, par value $.001 1K Feb 25, 2022 By trust for daughter
holding ENOV Common stock, par value $.001 1K Feb 25, 2022 By trust for daughter
holding ENOV Common stock, par value $.001 1K Feb 25, 2022 By trust for son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs").
F2 Reflects the certification of the performance criteria for PRSUs previously awarded in 2019. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2020 Fiscal Year-End" table on page 42 of Colfax Corporation's 2021 Proxy Statement as filed with the Securities and Exchange Commission on April 1, 2021.